JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.95% |
| 2 | Financials | 11.95% |
| 3 | Healthcare | 9.46% |
| 4 | Consumer Discretionary | 8.62% |
| 5 | Industrials | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Genesis Energy
GEL
$1.9B
| $43.8M | 0.01% |
2,137,890
+61,664
| +3% | +$1.24M |
|
1027
UDR
UDR
$12.1B
| $43.6M | 0.01% |
933,947
+124,691
| +15% | +$5.99M |
|
|
K
1028
DELISTED
Kellanova
K
| $43.6M | 0.01% |
671,180
+151,001
| +29% | +$9.15M |
|
1029
Moody's
MCO
$82.8B
| $43.6M | 0.01% |
183,555
+57,212
| +45% | +$12.7M |
|
1030
PUT
Petrobras
PBR
$118B
| $43.6M | 0.01% |
2,732,700
+197,900
| +8% | +$3.02M |
|
|
RARX
1031
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $43.4M | 0.01% |
924,425
+669,765
| +263% | +$29.6M |
|
|
TECX
1032
Tectonic Therapeutic
TECX
$639M
| $43.2M | 0.01% |
178,799
+14,858
| +9% | +$2.86M |
|
1033
CenterPoint Energy
CNP
$26.4B
| $43.2M | 0.01% |
1,583,451
+282,543
| +22% | +$7.68M |
|
1034
Franklin Resources
BEN
$17B
| $43.1M | 0.01% |
1,660,479
-1,889,462
| -53% | -$51.3M |
|
1035
Monarch Casino & Resort
MCRI
$2.17B
| $43.1M | 0.01% |
887,435
+97
| +0% | +$4.31K |
|
1036
Telus
TU
$15.1B
| $43.1M | 0.01% |
2,224,502
-651,714
| -23% | -$12.1M |
|
1037
Tyson Foods
TSN
$20.1B
| $43M | 0.01% |
472,329
-121,734
| -20% | -$10.5M |
|
1038
CALL
Procter & Gamble
PG
$340B
| $43M | 0.01% |
344,200
-203,100
| -37% | -$24.8M |
|
|
MMP
1039
CALL
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $42.8M | 0.01% |
+681,500
| New | +$42.5M |
|
1040
Howmet Aerospace
HWM
$113B
| $42.8M | 0.01% |
1,813,530
+595,611
| +49% | +$13.3M |
|
1041
Seagate
STX
$182B
| $42.7M | 0.01% |
718,109
-128,946
| -15% | -$7.41M |
|
1042
Envista
NVST
$4.53B
| $42.6M | 0.01% |
1,438,552
+475,513
| +49% | +$13.5M |
|
1043
Acco Brands
ACCO
$402M
| $42.5M | 0.01% |
4,544,423
-506,331
| -10% | -$4.79M |
|
1044
Bausch Health
BHC
$2.37B
| $42.5M | 0.01% |
1,420,480
-204,672
| -13% | -$5.32M |
|
1045
State Street DoubleLine Total Return Tactical ETF
TOTL
$3.99B
| $42.4M | 0.01% |
864,457
+277,470
| +47% | +$13.6M |
|
1046
Open Text
OTEX
$5.99B
| $42.3M | 0.01% |
960,724
-56,585
| -6% | -$2.38M |
|
1047
Chegg
CHGG
$94.8M
| $42.3M | 0.01% |
1,115,536
-428,880
| -28% | -$15M |
|
1048
United Bankshares
UBSI
$6.55B
| $42M | 0.01% |
1,085,141
+61,508
| +6% | +$2.37M |
|
1049
Dollar Tree
DLTR
$24.9B
| $41.9M | 0.01% |
445,886
+53,357
| +14% | +$5.6M |
|
1050
Meritage Homes
MTH
$4.69B
| $41.8M | 0.01% |
1,367,202
-246,724
| -15% | -$8.47M |
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.